Bay Area COVID-19 Testing Initiative to Assess Impact, Guide Safe Reopening of California Economy

A new large-scale, long-term research collaboration aims to better understand the spread of COVID-19 across the San Francisco Bay Area.

UCSF Health Re-Opens Mount Zion Hospital for Inpatient Care

Paramedics transport a mock patient into UCSF’s Mount Zion

Testing the Tests: COVID-19 Antibody Assays Scrutinized for Accuracy by UCSF, UC Berkeley Researchers

A project launched by UC San Francisco and UC Berkeley scientists evaluated some of the more than 120 available antibody test kits.

The Promise and Uncertainties of Antibody Testing for Coronavirus

As people around the world try to envision recovery from the COVID-19 pandemic, much attention has been paid to antibody testing as a way to identify people who have developed immunity to the virus. UCSF experts explain how antibody testing works, who it can be most useful for and why we should be...

UCSF Health Care Workers to Serve in Navajo Nation

The UCSF health care workers specialize in critical care, intensive care, acute care and hospital medicine.

COVID-19 Testing in Mission District, Bolinas to Inform Next Steps in Fight Against Disease

UCSF infectious disease researchers and community partners have launched an effort to provide comprehensive, voluntary COVID-19 testing to all residents of two distinctive Bay Area communities.

‘Contactless’ COVID-19 Trial to Test Common Anti-Inflammatory Drug

UC SFis recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.

Clinical Trial Testing if Common Anti-Inflammatory Drug Reduces Hospitalization, Death Caused by Conornavirus

UCSF is recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.

Clinical Trial Testing If Common Anti-Inflammatory Drug Reduces Hospitalization, Death Caused by Coronavirus

UCSF is recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.

New CRISPR-Based COVID-19 Test Kit Can Diagnose Infection in Less Than an Hour

While the widely used coronavirus PCR tests take about four hours to produce a result from a respiratory sample, the new DETECTR test developed by UCSF scientists takes only 45 minutes, rapidly accelerating the pace of diagnosis.